Showing results (21-30 of 62) with videos related to

Sort By:
Pageof 7
Asia Pacific Journal of Clinical Nutrition|September 18, 2017
Appropriate nutritional management in patients with impaired mastication and those with mild dysphagia: a multicenter study of the usefulness of novel foods processed and softened by enzymesTakashi Higashiguchi, Akihiro Ito, Hirofumi Nishiyama, et al.
Annals of Nutrition & Metabolism|July 9, 2018
Implementation of Intravenous Drip Infusion Therapy with Peripheral Venous Catheters and the Incidence of Related Complications in Home-Based Medical Care Settings in JapanNaomi Nakayama, Takashi Higashiguchi, Kozue Hanada, et al.
Wounds : a Compendium of Clinical Research and Practice|April 14, 2015
Experimental Research on Stimulation of Wound Healing by n-3 Fatty AcidsAkihiko Futamura, Takashi Higashiguchi, Akihiro Ito, et al.
Surgery Today|September 28, 2010
Rectal obstruction by a giant pharmacobezoar composed of magnesium oxide: report of a caseYoshinobu Shigekawa, Yasuhito Kobayashi, Takashi Higashiguchi, et al.
Langenbeck'S Archives of Surgery|July 19, 2006
Preoperative evaluation of pelvic lateral lymph node of patients with lower rectal cancer: comparison study of MR imaging and CT in 53 patientsKazuo Arii, Katsunari Takifuji, Shozo Yokoyama, et al.
Biological & Pharmaceutical Bulletin|January 27, 2017
Effects of Combined Treatment with Branched-Chain Amino Acids, Citric Acid, L-Carnitine, Coenzyme Q10, Zinc, and Various Vitamins in Tumor-Bearing MiceHiroko Awa, Akihiko Futamura, Takashi Higashiguchi, et al.
Diseases of the Colon and Rectum|July 11, 2006
Survival in colorectal cancer patients with urinary tract invasionTsukasa Hotta, Katsunari Takifuji, Shozo Yokoyama, et al.
Anticancer Research|April 20, 2006
Potential predictors of long-term survival after surgery for patients with stage IV colorectal cancerTsukasa Hotta, Katsunari Takifuji, Kazuo Arii, et al.
Anticancer Research|April 20, 2006
Clinical impact of adjuvant chemotherapy on patients with stage III colorectal cancer: l-LV/5FU chemotherapy as a modified RPMI regimen is an independent prognostic factor for survivalTsukasa Hotta, Katsunari Takifuji, Kazuo Arii, et al.
Oncology Reports|July 14, 2005
Toxicity during l-LV/5FU adjuvant chemotherapy as a modified RPMI regimen for patients with colorectal cancerTsukasa Hotta, Katsunari Takifuji, Kazuo Arii, et al.
Pageof 7